Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

A study at MedUni Vienna’s Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in skin cancer and describes their different immunomodulatory roles in the tumor environment. The results are relevant for the development of novel skin cancer therapies, particularly in the field of immunotherapy. The study was recently published in the journal Nature Communications.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *